Christopher Jm Williams

10PUBLICATIONS
72CO-AUTHORS
Predictive and prognostic markersProteomics and metabolomicsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 26, 2026
Systemic inflammation and prognosis in patients with RAS/BRAF wild-type metastatic colorectal cancer receiving anti-EGFR therapy: A real-world cohort study.

|Dec 15, 2025
ClusterNet: Classifying Single-Molecule Localization Microscopy Datasets with Graph-Based Deep Learning of Supracluster Structure.

Oliver Umney, Hayley Slaney, Christopher J M Williams

|May 01, 2025
Targeting the MAP Kinase Pathway in Colorectal Cancer: A Journey in Personalized Medicine.

Jordan W Appleyard, Christopher J M Williams, Paolo Manca

|Sep 24, 2024
Neoadjuvant immunotherapy for dMMR and pMMR colorectal cancers: therapeutic strategies and putative biomarkers of response.

Christopher J M Williams, Allyson M Peddle, Pashtoon M Kasi

|Jul 31, 2024
Evaluation of CD3 and CD8 T-Cell Immunohistochemistry for Prognostication and Prediction of Benefit From Adjuvant Chemotherapy in Early-Stage Colorectal Cancer Within the QUASAR Trial.

Christopher J M Williams, Richard Gray, Robert K Hills

|Jun 26, 2023
Associations between AI-Assisted Tumor Amphiregulin and Epiregulin IHC and Outcomes from Anti-EGFR Therapy in the Routine Management of Metastatic Colorectal Cancer.

Christopher J M Williams, Faye Elliott, Nancy Sapanara

Pageof 2

Frequent Collaborators

6 joint publications

Jenny Seligmann

5 joint publications

Nicholas West

4 joint publications

Philip Quirke

3 joint publications

Susan D Richman